Skip to main
ALHC

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 36%
Buy 45%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare Inc is strategically positioned to leverage the anticipated favorable 2026 rate update, especially as many managed care organizations are reducing benefits, granting ALHC a competitive edge through its Stars funding advantage. The company's integrated Medicare Advantage value-based care model is expected to foster long-term market share gains and above-average growth, supported by promising gross profit per member per month metrics projected to improve from $90-$150 in the first two years to over $230 in years three to five. Additionally, the stronger-than-expected 2026 MA rate update may enhance membership growth and improve cohort margin maturation, further contributing to the company's positive financial outlook.

Bears say

Alignment Healthcare Inc faces challenges that contribute to a negative outlook, primarily due to data friction across different payors and inconsistent outcomes from employed or affiliated primary care providers (PCPs). While the company has reported lower average daily costs (ADK) amidst increased healthcare utilization, the implications of the rising costs and complexities related to the Medicare Advantage market can strain financial performance. Additionally, despite the company’s above-average EBITDA growth relative to peers, its valuation multiple remains slightly elevated, suggesting that potential risks may not be fully reflected in the stock price.

Alignment Healthcare (ALHC) has been analyzed by 11 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 45% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 11 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22.05, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22.05, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.